Publications by authors named "D R Chaple"

Article Synopsis
  • Cardiovascular diseases affect 608 million people globally, causing 32% of deaths, and often require combination therapy targeting the RAAS and Neprilysin systems.
  • A new multi-target in-silico modeling technique (mt-QSAR) was developed to assess the inhibitory effects on Neprilysin and Angiotensin-converting enzymes, achieving around 90% accuracy using various machine learning algorithms on 983 chemicals.
  • The study’s findings, including virtual screening and molecular dynamics simulations, aim to aid in identifying new multi-targeted treatments for cardiovascular conditions.
View Article and Find Full Text PDF

Sarcopenia is a musculoskeletal disease that reduces muscle mass and strength in older individuals. The study investigates the effects of azilsartan (AZL) on skeletal muscle loss in natural sarcopenic rats. Male Sprague-Dawley rats aged 4-6 months and 18-21 months were selected as young-matched control and natural-aged (sarcopenic) rats, respectively.

View Article and Find Full Text PDF

Cardiovascular diseases (CVD) such as heart failure, stroke, and hypertension affect 64.3 million people worldwide and are responsible for 30% of all deaths. Primary inhibition of the angiotensin-converting enzyme (ACE) is significant in the management of CVD.

View Article and Find Full Text PDF

Unlabelled: The severe acute respiratory syndrome COVID-19 declared a global pandemic by WHO has become the present wellbeing worry to the whole world. There is an emergent need to search for possible medications. We report in this study a molecular docking study of eighteen molecules with the main protease (M) responsible for the replication of SARS-CoV-2 virus.

View Article and Find Full Text PDF